Professional Documents
Culture Documents
Issue 6
Include the following: Name What type of contractor you are e.g. pharmacy, appliance, dispensing doctor or GP who dispenses personally administered items (PADM) Trading name If youve got a hint or tip that you would like us to write about in a future edition, please email it to communicationsteam@nhsbsa.nhs.uk.
Payment for Specials and Imported Unlicensed Medicines - Drug Tariff Part VIIIB
Part VIIIB was introduced to the Drug Tariff with effect from 1 November 2011, comprising a limited list of unlicensed medicines for which reimbursement is made based on the basic price listed. Specials and imported unlicensed medicines included in Part VIIIB are listed with a minimum quantity and corresponding price which is payable for any amount prescribed up to and including the minimum quantity. Quantities in excess of the minimum quantity are paid at the additional price per ml/g/tab/cap stated, unless in a special container in which case the relevant number of special containers will be reimbursed.
Specials and imported unlicensed medicines not included in Part VIIIB will be reimbursed depending on how the item has been obtained. Where extemporaneously dispensed under the manufacturing part of the Section 10 exemption from the Medicines Act 1968, the cost of the
ingredients used will be reimbursed. Where obtained from a If an unlicensed medicine not listed manufacturer holding a MHRA specials licence, reimbursement in Drug Tariff Part VIIIB is manufactured will be made according to the price endorsed by the contractor. under a specials licence or sourced under The price endorsed should be the invoice price less any an importers licence issued by the MHRA, discount or rebate linked to the procurement of the item. the invoice price less any discount/rebates should be endorsed. That is the actual price See the Drug Tariff for full details. paid for the product.
Contents
Page 2 New Pharmacy Contractor Additional Fees Drug Tariff Part IIIA
New Pharmacy Contractor Additional Fees and Endorsements Drug Tariff Part IIIA
Where a preparation has been manufactured under an MHRA specials licence or sourced under an MHRA importers licence, contractors can claim an additional fee by endorsing SP. Please note that SP should not be endorsed under any other circumstances. Where a preparation has been prepared under the section 10 exemption from the Medicines Act 1968, contractors can claim an additional fee by endorsing ED. Please note that ED should not be endorsed under any other circumstances. DNG endorsements are no longer required - no discount will be deducted where specials/imports not included in Part VIIIB are dispensed. Out of Pocket Expenses cannot be claimed for specials/imports and should no longer be included in the declaration on the FP34C. Broken Bulk cannot be claimed for specials/imports, although Broken Bulk can be claimed on the ingredients where a preparation has been prepared under the section 10 exemption from the Medicines Act 1968. See the Drug Tariff for full details.
Midazolam
With effect from 1 November 2011 Midazolam 10mg/ml oral solution is included in Part VIIIB of the Drug Tariff, listed as a minimum volume pack of 5ml plus a price per extra ml above this minimum volume. Contractors will be reimbursed at the price for 1 x 5ml minimum volume pack plus the price of the 1ml pack for every extra ml dispensed above 5ml, unless it is clearly endorsed that the whole quantity has been dispensed in containers with an integral means of administration, e.g. 20ml prescribed and the contractor endorses 20ml/5ml or 4 x 5ml. The following are all covered by the Part VIIIB entry: Standard (STD), Sugar Free (SF), Lactose Free (LF), Colour Free (CF) and Oromucosal formulations Both Midazolam maleate 10mg/ml oral solution and Midazolam Hydrochloride 10mg/ml oral solution Midazolam 10mg/1ml oromucosal solution Pre-Filled Oral syringes (1 Pre-Filled Syringe = 1ml) Midazolam 10mg/ml buccal solution
Where Midazolam 10mg/ml Liquid is prescribed, contractors need to endorse the exact pharmaceutical form dispensed, e.g. solution or suspension. This will ensure prompt and correct reimbursement. Where this information is not endorsed, the item will be referred back.
Advance Payments
To ensure an Advance Payment is received, it is essential to send your prescription batch to NHS Prescription Services in a timely manner. Drug Tariff Part I Clause 5 states that forms should be despatched no later than the fifth day of the month following that in which the supply was made. If batches are received too late in the month, there is a possibility that no Advance Payment can be made.
You may wish to consider selling PPCs; you can register with the How to sell the PPC NHSBSA on the PPC websales website. Pharmacies are reminded to fully complete PPC application forms (form FP95) and they should be sent with the completed sales advice slip (PE31) to the NHSBSA. When completing the PE31, please ensure you provide: Your pharmacy details (name, address, telephone number) OCS code - begins with the letter F The number of PPCs (3-month and 12-month) sold The name, signature and position of sender The date of sale
Incorrectly completed details can cause: delayed issue of the PPC to the customer financial implications for the customer delayed adjustments to your payments It is important that you send PE31 and application forms to us on a daily basis, so that we can issue the PPC to the customer without delay. Please dont send any payment with the application forms. You should retain the money paid for the certificates and this will be deducted from your monthly payment. These payments will show on your monthly schedule under details of other amounts authorised. The NHSBSA will supply additional PE31s and reply envelopes. You can obtain these by calling our Customer Contact Section on 0845 6018076. Additional FP95 application forms can be obtained from your Primary Care Trust (PCT) Form Supplies Department / Agency when you need some more. If you require assistance with the completion of these forms, please contact our Technical and Procedural Section on 0191 2034945.
Reasons for Referred Back items and how to reduce the volume you receive
Referred back items account for 0.22% of the overall total of dispensed items. Some of the common reasons for referring items back, and the information we require, are listed below: Reason Generic order for a drug not listed in Drug Tariff Part VIIIA. Pharmaceutical form not prescribed and more than one pharmaceutical form is available Ambiguous pharmaceutical form prescribed Action Required Endorsement of brand, manufacturer, or wholesaler required Endorse with pharmaceutical form dispensed Endorse with pharmaceutical form dispensed Examples of products where information is often missing Alimemazine 10mg tablets Tramadol modified release capsules Venlafaxine 75mg and 150mg modified release tablets Prednisolone 5mg Donepezil Tamsulosin M/R Epaderm Emollient Please indicate whether cream or ointment was dispensed Glyceryl Trinitrate spray Please indicate whether pump or aerosol was dispensed Amoxicillin 250mg tablets only capsules are available Sterile Dressing Pack x 1 box Please indicate how many dressings were dispensed for an order of one box. Dianette available from Bayer Plc and Generics UK Nifedpress MR 20 tablets available from Dexcel-Pharma Ltd, Actavis UK Ltd and Teva UK Ltd Lansinoh lanolin ointment
Endorse with pharmaceutical form dispensed Endorse with number / quantity dispensed
Branded items where more than one supplier supplies that brand
For less common products (other than specials and imported products) where a price is not held on NHS Prescription Services internal systems.
Endorse the total net price for the prescribed quantity (before discount and ex VAT)
To avoid delays to payment, please provide NHS Prescription Services with enough information to allow prescriptions to be processed. For further information on endorsing guidelines please refer to our endorsing guide. Alternatively, call the Help Desk on 0845 6101171.
Schedule of Payments
You may have noticed some changes to your schedule of payments over the last two months. This is to reflect changes to the Drug Tariff in relation to CIP compensation payments and New Medicine Services payments.
A sticky problem!
Its important that contractors dont put stickers on prescription forms to identify New Medicine Services activity or to identify Expensive items. Not only can residue from the stickers jam the scanning A further change will be shown from November 2011 machines used during the prescription Schedule of Payment (Payment date 1 February 2012) to processing activity, but they could affect reflect the changes made to the Professional Fee structure, as the accuracy of the information set out in Drug Tariff Part IIIA Additional Fees and will include captured from the prescription the Unlicensed Medicines fees. These fees will be displayed under form. the heading of Prescription Fees - Additional Fees found on the first page of the schedule.
For further information please contact the Prescription Pricing Helpdesk on: 0845 610 1171 or email: prescriptionpricinghelpdesk@ppa.nhs.uk